Parkinson’s disease (PD) is a neurodegenerative condition characterised by the death of dopaminergic neurons, primarily in the substantia nigra, over time. The gold standard medicine for managing Parkinson’s disease (PD) and controlling its symptoms is L-3,4-dihydroxyphenylalanine (LD). However, the formation of pro-oxidant intermediates resulting from LD’s autoxidation could produce...